McKesson Corp.

Company Snapshot

Founded: 1833
Entity Type: Public
Employees: 45,000
Region: U.S.
Revenue: $359,051.0 Millions
Revenue Year: 2024
Segment: U.S. Pharmaceutical
Headquarter: Texas, U.S.
Key Geographics: U.S.
Corporate Address: 6555 State Hwy 161, Irving, Texas 75039 U.S. Tel. +1-972-446-4800 www.mckesson.com

Company Overview

McKesson Corp. offers diversified healthcare services and partners with biopharmaceutical companies, healthcare providers, pharmacies and manufacturers, to deliver products, and services that enhance the accessibility and affordability of quality healthcare. McKesson operates through four business segments: U.S. Pharmaceutical, Prescription Technology Solutions, Medical-Surgical Solutions, and International.

The Medical-Surgical Solutions segment supports alternate site healthcare providers by offering medical supply distribution, logistics and biomedical equipment maintenance. Its customer base includes physician offices, surgical centers, post-acute care facilities, hospital reference labs and home healthcare organizations. The segment offers infusion pumps, lab instruments, pharmaceuticals, and medical-surgical supplies such as gloves, syringes, needles and wound care products.

Financial Highlights (FY 2024)

Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
R&D expenses: ***
Operating Income: ***

This information is available for BCC Research members only.

McKesson Corp. In Reports

Global Healthcare Predictive Analytics Markets

According to BCC Research detailed report on healthcare predictive analytics market includes global revenue ($ Million) for the base year of 2024 and estimated data for 2025 and the forecast period 2026 through 2030.

Global MedTech Healthcare IT Industry Competitive Landscape

BCC Research Market Analyst says global market for medical devices was valued at $810.4 billion in 2024 and is projected to reach $1.4 trillion by the end of 2030.

Global Patient Portal Market

According to BCC Research Report The market is projected to grow from $2.9 billion in 2022 to $9.4 billion in 2028, at a compound annual growth rate (CAGR) of 22.3%.

Company's Business Segments

  • U.S. Pharmaceutical : U.S. Pharmaceutical segment provides Distribution, Logistics Services for Branded, Generic, Specialty, Biosimilar, OTC Pharmaceutical Drugs along with Other Healthcare-related Products to customers.
  • Prescription Technology Solutions : Prescription Technology Solutions segment works across Healthcare to connect Patients, Pharmacies, Providers, Pharmacy benefit Managers, Health Plans, Biopharma to deliver medication access solutions that support patients from first prescription fill to Ongoing Therapy, regardless of their insurance coverage.
  • Medical-Surgical Solutions : Medical-Surgical Solutions segment delivers Medical-supply Distribution, Logistics, Biomedical Maintenance, Other services to Healthcare providers across the alternate-site spectrum.
  • International : International segment provides Distribution, Services to Wholesale, Institutional, Retail Customers in Canada, Europe where we Own, Partner, Franchise with Retail Pharmacies.

Applications/End User Industries

  • Wholesalers
  • Logistics
  • Pharmacies
  • Hospitals
  • Oncology
  • Physicians
  • Retail Customers
  • Institutional
  • Suppliers
  • Medical-Supply Distribution
  • Biomedical Maintenance
  • Home Health Agencies
  • Hospital Reference Labs
  • Post-Acute Care Facilities
  • Physician Offices
  • Surgery Centers
  • Biopharma
  • Health Plans
  • Specialty Practices
  • Pharmaceutical Manufacturers
AI Sentiment